Will hopefully get some clarification what this means in due course. (i.r. from someone that knows what they're talking about, not someone looking at charts)
The effects observed following treatment with the low dose of trofinetide (35 mg/kg twice daily) were less consistent and the magnitude of improvement did not meet pre-specified targets, but there was evidence of a dose response. Given the excellent tolerability profile of trofinetide and the observed dose response profile, there is a clear rationale to study higher doses.
- Forums
- ASX - By Stock
- Ann: Trofinetide successful in Phase 2 trial in Fragile X
Will hopefully get some clarification what this means in due...
-
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.66 |
Change
0.440(2.18%) |
Mkt cap ! $2.671B |
Open | High | Low | Value | Volume |
$20.45 | $21.10 | $20.39 | $4.623M | 222.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 117 | $20.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.66 | 841 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 20.660 |
5 | 117 | 20.650 |
6 | 3661 | 20.640 |
3 | 188 | 20.630 |
1 | 136 | 20.620 |
Price($) | Vol. | No. |
---|---|---|
20.670 | 22 | 2 |
20.680 | 99 | 4 |
20.690 | 388 | 11 |
20.700 | 171 | 2 |
20.710 | 229 | 3 |
Last trade - 13.34pm 26/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |